Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
and computational biologists aiming to examine the factors and complexes governing the production and turnover of eukaryotic transcriptomes. What we offer The successful applicant is offered: Access
-
innovative research, contracted policy advice, and education. We offer professional laboratories, greenhouses, semi-field, and field-scale research facilities, advanced computing capacities as
-
scripting (R, Python) and programming. Experience with High-Performance Computing (HPC) environments and the management/analysis of large datasets. The ability to communicate effectively in English (both
-
procedure Shortlisting is used. This means that after the deadline for applications – and with the assistance from the assessment committee chairman, and the appointment committee if necessary, – the head of
-
electron lasers (XFEL). Optical phase change materials can be reversibly switched between amorphous and crystalline states on fast timescales and are enabling materials for emerging photonic computing
-
will gain: Strong expertise in statistical and computational methods for privacy Experience working with unique, real-world health data Collaboration with an interdisciplinary research team across data
-
– and with the assistance from the assessment committee chairman, and the appointment committee if necessary, – the head of department selects the candidates to be evaluated. All applicants will be
-
chairman, and the appointment committee if necessary, – the head of department selects the candidates to be evaluated. All applicants will be notified whether or not their applications have been sent
-
Positions Application Deadline 15 Sep 2026 - 12:00 (Europe/Copenhagen) Country Denmark Type of Contract Temporary Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded
-
the opportunity to contribute to an internationally competitive research programme at the interface of proteomics technology development, regulatory protein biology, and cancer research. Expected start date and